Naoya Miura

PI3K/p110δ is a novel therapeutic target in multiple myeloma

Hiroshi Ikeda, Teru Hideshima, Mariateresa Fulciniti et al. · Blood · 2010 · 188 citations · Full text

Medicine, Cancer Biology, Oncology +12

Reduction of Immunocompetent T Cells Followed by Prolonged Lymphopenia in Severe Sepsis in the Elderly*

Shigeaki Inoue, Kyoko Suzuki-Utsunomiya, Yoshinori Okada et al. · Critical Care Medicine · 2013 · 179 citations

Life Sciences, Geriatric Medicine, Immunology +16

Development of a lipoplex-type mRNA carrier composed of an ionizable lipid with a vitamin E scaffold and the KALA peptide for use as an ex vivo dendritic cell-based cancer vaccine

Naho Tateshita, Naoya Miura, Hiroki Tanaka et al. · Journal of Controlled Release · 2019 · 94 citations

Pharmacy, Molecular Pharmaceutics, Pharmaceutical Biotechnology +17

A fatal case of MAM-2201 poisoning

Takeshi Saito, Akira Namera, Naoya Miura et al. · Forensic Toxicology · 2013 · 87 citations

Pharmacy, Clinical Toxicology, Toxicology +11

A KALA-modified lipid nanoparticle containing CpG-free plasmid DNA as a potential DNA vaccine carrier for antigen presentation and as an immune-stimulative adjuvant

Naoya Miura, Sharif M. Shaheen, Hidetaka Akita et al. · Nucleic Acids Research · 2015 · 58 citations · Full text

Pharmacy, Biotechnology, Immunology +17